Stock Events

Stock Events

Imunon 

$3.04
74
+$0.05+1.67% Today

Statistics

Day High
3.08
Day Low
2.85
52W High
41.22
52W Low
2.52
Volume
18,040
Avg. Volume
93,255
Mkt Cap
9.33M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-5.25
-3.58
-1.92
-0.25
Expected EPS
-0.808225
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-37.24MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IMNN. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that competes with Imunon in the development of treatments for infectious diseases, including HIV and hepatitis, areas where Imunon also aims to innovate.
Merck
MRK
Mkt Cap214.76B
Merck & Co. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals, including cancer treatments and vaccines, directly competing with Imunon's focus on oncology and immunotherapy.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb operates in the same biopharmaceutical space as Imunon, focusing on cancer, HIV/AIDS, cardiovascular disease, and immune disorders, making it a direct competitor.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotech company focusing on human therapeutics, including treatments for cancer and inflammatory diseases, competing with Imunon's research and development in similar areas.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical corporation that competes with Imunon in the development and marketing of drugs and vaccines for a wide range of diseases, including those targeted by Imunon's pipeline.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that competes with Imunon in developing innovative medicines for various diseases, including cancer and autoimmune diseases, areas of focus for Imunon.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a healthcare company that competes with Imunon in the fields of pharmaceuticals and diagnostics, particularly in oncology and immunology.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a research-based biopharmaceutical company that competes with Imunon in developing therapies for complex and serious diseases, including cancer and immune-mediated diseases.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a diversified healthcare company that competes with Imunon across several areas, including pharmaceuticals and research and development in immunology and oncology.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of medicines for serious medical conditions, competing with Imunon in the area of immunotherapy and targeted cancer treatments.

About

Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was founded in 1982 and is based in Lawrenceville, New Jersey.
Show more...
CEO
Mr. Michael H. Tardugno
Employees
25
Country
US
ISIN
US15117N7012

Listings

F
DE
CBO0.F
LSE
GB
0HUZ.LSE
XNAS
US
IMNN
BOATS
BOATS
IMNN.BOATS

0 Comments

Share your thoughts

FAQ

What is Imunon stock price today?▼
The current price of IMNN is $3.04 USD — it has increased by +1.67% in the past 24 hours. Watch Imunon stock price performance more closely on the chart.
What is Imunon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Imunon stocks are traded under the ticker IMNN.
Is Imunon stock price growing?▼
IMNN stock has risen by +13.65% compared to the previous week, the month change is a -6.38% fall, over the last year Imunon has showed a +237.33% increase.
What is Imunon market cap?▼
Today Imunon has the market capitalization of 9.33M
When is the next Imunon earnings date?▼
Imunon is going to release the next earnings report on May 18, 2026.
What were Imunon earnings last quarter?▼
IMNN earnings for the last quarter are -1.3 USD per share, whereas the estimation was -1.66 USD resulting in a +21.69% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Imunon revenue for the last year?▼
Imunon revenue for the last year amounts to 0 USD.
What is Imunon net income for the last year?▼
IMNN net income for the last year is -37.24M USD.
How many employees does Imunon have?▼
As of April 02, 2026, the company has 25 employees.
In which sector is Imunon located?▼
Imunon operates in the Health Care sector.
When did Imunon complete a stock split?▼
The last stock split for Imunon was on August 07, 2025 with a ratio of 1.15:1.
Where is Imunon headquartered?▼
Imunon is headquartered in Lawrenceville, US.